bioRxivCell BiologyPreprint
Renal Cl-/H+ antiporter ClC-5 regulates collagen production and release in Dent Disease models
M. Duran, G. Ariceta, M. E. Semidey, C. Castells-Esteve, B. Lu, A. Meseguer, G. Cantero
Abstract
Mutations in the Cl-/H+ antiporter ClC-5 cause Dents Disease 1 (DD1), a rare primary tubulopathy that eventually progresses to renal failure. In fact, even with normal kidney function, DD1 patients present renal tubulointerstitial fibrosis. However, the link between ClC-5 loss-of-function and renal fibrosis remains unclear. Here, we have shown that DD1 mice models lacking ClC-5 present higher renal collagen deposition and fibrosis. Accordingly, deletion of ClC-5 in human renal proximal tubule epithelial cells (CLCN5 KD) recapitulates this effect. We have demonstrated that CLCN5 KD causes an increase of collagen I (Col I) and IV (Col IV) intracellular levels by promoting their transcription through {beta}-catenin pathway and impairing their lysosomal-mediated degradation. In addition, CLCN5 KD cells release more Col I and IV at the extracellular space that form fibres with altered properties and resistance to removal compared to control cells. Altogether, we describe a new regulatory mechanism for collagens production and release by ClC-5, which is altered in DD1 and provides a better understanding of disease progression to renal fibrosis. SIGNIFICANCE STATEMENTRenal fibrosis is a common pathologic process occurring as consequence of chronic kidney injury and leading to renal dysfunction. Dents Disease is a rare renal pathology that progresses to chronic kidney disease and tubulointerstitial fibrosis. Interestingly, it is caused by mutations in a single gene called CLCN5, therefore it can help understanding the cellular mechanisms of renal fibrosis. Using cellular and mice models of the disease, we describe a mechanism linking CLCN5 function, cell differentiation and regulation of collagen levels, major component of extracellular matrix and important player for renal fibrosis development. In conclusion, our results provide a link between CLCN5 and altered collagen deposition, which could be relevant for other renal Fanconi syndrome related diseases also progressing to fibrosis.
- organism: mouse
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Global gene-expression analysis reveals the molecular processes underlying ClC-5 loss-of-function in novel Dent Disease 1 cellular models
M. Duran, C. Burballa, … A. Meseguer·bioRxiv·Dec 16, 2020
- TMEM9 and SEC22B interact with ClC-5 to shape renal proximal tubule function and Dent's Disease type I pathogenesis
Mónica Durán, Andrea Casal-Pardo, … Gerard Cantero-Recasens·bioRxiv·Nov 3, 2025
- A Drosophila model for Dent disease reveals impaired ER export of Cubilin as pathogenic mechanism
Salómon Christer, Zvonimir Marelja, … Matias Simons·bioRxiv·Mar 5, 2025
- Tissular glucocorticoid reactivating enzyme 11beta-HSD1 drives pathogenic myofibroblast differentiation in chronic kidney disease
Grégoire Arnoux, David Legouis, … Eric Féraille·bioRxiv·Jan 9, 2025
- Molecular Simulations Meet Personalized Medicine. The Mechanism of Action of ClC-5 Antiporter and the Origin of Dent's Disease
Veronica Macaluso, Carles Perez‐Lopez, … Modesto Orozco·PNAS NexusPeer-reviewed·Oct 31, 2025
- Aldosterone mediates potassium-induced kidney fibrosis through tubular and mesenchymal mineralocorticoid receptor activation
T. CHARLEMAGNE, A. SASSI, … V. Olivier·bioRxiv·Jun 15, 2022